{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:39Z","timestamp":1792787859629,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tampere University","id":[{"id":"https:\/\/ror.org\/033003e23","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04456-z","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:56:02Z","timestamp":1782863762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Flow rate dependence of salbutamol dose with various valved holding chambers in vitro"],"prefix":"10.1186","volume":"26","author":[{"given":"Ville","family":"Vartiainen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri","family":"Lehtim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Csonka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Csonka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"4456_CR1","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention. 2024. https:\/\/ginasthma.org\/2024-report\/."},{"key":"4456_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.chest.2016.03.041","volume":"150","author":"J Sanchis","year":"2016","unstructured":"Sanchis J, Gich I, Pedersen S, Aerosol Drug Management Improvement Team (ADMIT). Systematic review of errors in inhaler use. Chest. 2016;150:394\u2013406.","journal-title":"Chest"},{"key":"4456_CR3","doi-asserted-by":"publisher","unstructured":"Haughney J, Pertsovskaya I, McKnight E, O\u2019Driscoll M, Usmani OS. Peak inspiratory flow measured at different inhaler resistances in patients with asthma. J Allergy Clin Immunol Pract. 2021;9(2):890\u20136. https:\/\/doi.org\/10.1016\/j.jaip.2020.09.026.","DOI":"10.1016\/j.jaip.2020.09.026"},{"key":"4456_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1517\/17425240802637862","volume":"6","author":"F Lavorini","year":"2009","unstructured":"Lavorini F, Fontana GA. Targeting drugs to the airways: the role of spacer devices. Expert Opin Drug Deliv. 2009;6:91\u2013102.","journal-title":"Expert Opin Drug Deliv"},{"key":"4456_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40413-015-0075-y","volume":"8","author":"D Price","year":"2015","unstructured":"Price D, Harrow B, Small M, Pike J, Higgins V. Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians. World Allergy Organ J. 2015;8:26.","journal-title":"World Allergy Organ J"},{"key":"4456_CR6","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.acap.2016.04.006","volume":"16","author":"C Gillette","year":"2016","unstructured":"Gillette C, Rockich-Winston N, Kuhn JA, Flesher S, Shepherd M. Inhaler technique in children with asthma: a systematic review. Acad Pediatr. 2016;16:605\u201315.","journal-title":"Acad Pediatr"},{"key":"4456_CR7","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1183\/09031936.97.10061345","volume":"10","author":"PW Barry","year":"1997","unstructured":"Barry PW, O\u2019Callaghan C. In vitro comparison of the amount of salbutamol available for inhalation from different formulations used with different spacer devices. Eur Respir J. 1997;10:1345\u20138.","journal-title":"Eur Respir J"},{"key":"4456_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1089\/jam.2004.17.225","volume":"17","author":"JC Dubus","year":"2004","unstructured":"Dubus JC, Anh\u00f8j J. Inhaled steroid delivery from small-volume holding chambers depends on age, holding chamber, and interface in children. J Aerosol Med. 2004;17:225\u201330.","journal-title":"J Aerosol Med"},{"issue":"1","key":"4456_CR9","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00158-2018","volume":"5","author":"P Csonka","year":"2019","unstructured":"Csonka P, Lehtim\u00e4ki L. Valved holding chamber drug delivery is dependent on breathing pattern and device design. ERJ Open Res. 2019;5(1):00158-2018.","journal-title":"ERJ Open Res"},{"key":"4456_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1089\/jam.1997.10.341","volume":"10","author":"JP Mitchell","year":"1997","unstructured":"Mitchell JP, Nagel MW. In vitro performance testing of three small volume-holding chambers under conditions that correspond with use by infants and small children. J Aerosol Med. 1997;10:341\u20139.","journal-title":"J Aerosol Med"},{"key":"4456_CR11","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1378\/chest.114.6.1676","volume":"114","author":"WH Finlay","year":"1998","unstructured":"Finlay WH, Zuberbuhler P. In vitro comparison of beclomethasone and salbutamol metered-dose inhaler aerosols inhaled during pediatric tidal breathing from four valved holding chambers. Chest. 1998;114:1676\u201380.","journal-title":"Chest"},{"key":"4456_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/apa.14965","volume":"109","author":"J H\u00e4selbarth","year":"2020","unstructured":"H\u00e4selbarth J, Svedmyr J. Paediatric in vitro models showed significant variations in fluticasone proprionate output from valved holding chambers. Acta Paediatr. 2020;109:565\u201372.","journal-title":"Acta Paediatr"},{"key":"4456_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1089\/08942680260473506","volume":"15","author":"MW Nagel","year":"2002","unstructured":"Nagel MW, Wiersema KJ, Bates SL, Mitchell JP. Performance of large- and small-volume valved holding chambers with a new combination long-term bronchodilator\/anti-inflammatory formulation delivered by pressurized metered dose inhaler. J Aerosol Med. 2002;15:427\u201333.","journal-title":"J Aerosol Med"},{"key":"4456_CR14","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.jaip.2020.09.026","volume":"9","author":"J Haughney","year":"2021","unstructured":"Haughney J, et al. Peak inspiratory flow measured at different inhaler resistances in patients with asthma. J Allergy Clin Immunol Pract. 2021;9:890\u20136.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"4456_CR15","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1136\/thx.51.10.981","volume":"51","author":"DJ Clark","year":"1996","unstructured":"Clark DJ, Lipworth BJ. Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device. Thorax. 1996;51:981\u20134.","journal-title":"Thorax"},{"key":"4456_CR16","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1136\/thx.51.10.985","volume":"51","author":"JH Wildhaber","year":"1996","unstructured":"Wildhaber JH, et al. Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants. Thorax. 1996;51:985\u20138.","journal-title":"Thorax"},{"key":"4456_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2019.101857","author":"P Csonka","year":"2019","unstructured":"Csonka P, Lehtim\u00e4ki L. Antistatic treatment and salbutamol dosing have variable effect on drug delivery of valved holding chambers. Pulm Pharmacol Ther. 2019;59:101857. https:\/\/doi.org\/10.1016\/j.pupt.2019.101857.","journal-title":"Pulm Pharmacol Ther"},{"key":"4456_CR18","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1183\/09031936.94.07091707","volume":"7","author":"PW Barry","year":"1994","unstructured":"Barry PW, O\u2019Callaghan C. Multiple actuations of salbutamol MDI into a spacer device reduce the amount of drug recovered in the respirable range. Eur Respir J. 1994;7:1707\u20139.","journal-title":"Eur Respir J"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04456-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04456-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04456-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:06:05Z","timestamp":1789689965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04456-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4456"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04456-z","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable as the study did not involve human subjects. Experiments were carried out fully\n                      in vitro.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"VV has received consultation and lecture fees from Orion pharma. LL has received fees for consultations, lectures and advisory board meetings from ALK, AstraZeneca, Berlin-Chemie, Boehringer Ingelheim, GSK, Menarini, Novartis, Orion and Sanofi. PC and MC report no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"414"}}